Halozyme Therapeutics, Inc. (HALO) Expected to Post Earnings of -$0.21 Per Share


Analysts predict that Halozyme Therapeutics, Inc. will post earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Halozyme Therapeutics' earnings.



from Biotech News